Advanced company searchLink opens in new window

ENTERPRISE THERAPEUTICS LTD

Company number 09022750

Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
20 Apr 2018 RESOLUTIONS Resolutions
  • RES10 ‐ Resolution of allotment of securities
  • RES11 ‐ Resolution of removal of pre-emption rights
  • RES01 ‐ Resolution of adoption of Articles of Association
19 Apr 2018 SH01 Statement of capital following an allotment of shares on 6 April 2018
  • GBP 114.29772
11 Apr 2018 AP01 Appointment of David Morris as a director on 6 April 2018
10 Apr 2018 PSC07 Cessation of Epidarex Capital Partners Limited as a person with significant control on 6 April 2018
10 Apr 2018 AP01 Appointment of Dr Bobby G. Soni as a director on 6 April 2018
10 Apr 2018 TM01 Termination of appointment of Ip2Ipo Services Limited as a director on 6 April 2018
10 Apr 2018 AP01 Appointment of Geert-Jan Mulder as a director on 6 April 2018
10 Apr 2018 AP01 Appointment of Alexander Volker Mayweg as a director on 6 April 2018
10 Apr 2018 TM01 Termination of appointment of Martin Gosling as a director on 6 April 2018
12 Mar 2018 PSC05 Change of details for Imperial Innovations Businesses Llp as a person with significant control on 4 January 2017
28 Feb 2018 AA Full accounts made up to 31 December 2017
16 Feb 2018 AP02 Appointment of Ip2Ipo Services Limited as a director on 15 February 2018
16 Feb 2018 TM01 Termination of appointment of Robbie Woodman as a director on 15 February 2018
25 Sep 2017 RESOLUTIONS Resolutions
  • RES10 ‐ Resolution of allotment of securities
  • RES01 ‐ Resolution of adoption of Articles of Association
21 Sep 2017 CH01 Director's details changed for Mrs Elizabeth Roper on 21 September 2017
21 Sep 2017 CH01 Director's details changed for Dr Peter Michael Finan on 21 September 2017
20 Sep 2017 SH01 Statement of capital following an allotment of shares on 19 September 2017
  • GBP 51.00816
01 Sep 2017 PSC05 Change of details for Epidarex Capital Partners Limited as a person with significant control on 15 August 2017
18 May 2017 AA Full accounts made up to 31 December 2016
18 May 2017 CS01 Confirmation statement made on 2 May 2017 with updates
16 May 2017 CH01 Director's details changed for Dr Robbie Woodman on 16 May 2017
05 May 2017 SH01 Statement of capital following an allotment of shares on 5 May 2017
  • GBP 50.32387
04 May 2017 AA01 Previous accounting period shortened from 31 May 2017 to 31 December 2016
10 Apr 2017 SH01 Statement of capital following an allotment of shares on 7 April 2017
  • GBP 39.32737
14 Feb 2017 AA Full accounts made up to 31 May 2016